A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of one or multiple drugs of abuse in a clinical specimen.
| Company | Devices | Share |
|---|---|---|
| Biochemical Diagnostics Inc | 328 | 45% |
| Utak Laboratories, Inc. | 322 | 44% |
| Lin-Zhi International, Inc. | 13 | 2% |
| Medtox Diagnostics, Inc. | 11 | 2% |
| Horiba Instruments Incorporated | 10 | 1% |
| Abbott Laboratories | 9 | 1% |
| Microgenics Corporation | 6 | 1% |
| Siemens Healthcare Diagnostics Inc. | 6 | 1% |
| Chromsystems Instruments + Chemicals Gmbh | 4 | 1% |
| Beckman Coulter, Inc. | 3 | 0% |
| Randox Laboratories Limited | 2 | 0% |
| Genabio Diagnostics Inc. | 2 | 0% |
Company = labeler of record on GUDID. 18 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| DIF | Drug Mixture Control Materials | 422 |
| LAS | Drug Specific Control Materials | 332 |
| DIF | Drug mixture control materials | 11 |
| DIF | DRUG MIXTURE CONTROL MATERIALS | 8 |
| LAS | DRUG SPECIFIC CONTROL MATERIALS | 2 |
| DKB | Calibrators, Drug Mixture | 1 |
Use these as the dimensions to specify in a tender line.
724 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Multiple drugs of abuse IVD, control", from 18 companies. The largest labeler is Biochemical Diagnostics Inc with 45% of records.
DIF (Drug Mixture Control Materials), LAS (Drug Specific Control Materials), DIF (Drug mixture control materials), DIF (DRUG MIXTURE CONTROL MATERIALS)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add multiple drugs of abuse ivd, control to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.